Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its holdings in Doximity, Inc. (NASDAQ:DOCS) by 4.4% in the third quarter, Holdings Channel reports. The fund owned 753,001 shares of the company’s stock after buying an additional 31,966 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Doximity were worth $32,808,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. First Horizon Advisors Inc. raised its holdings in Doximity by 22.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock valued at $91,000 after acquiring an additional 384 shares during the last quarter. GAMMA Investing LLC raised its holdings in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after acquiring an additional 412 shares during the last quarter. Van ECK Associates Corp raised its holdings in Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock valued at $72,000 after acquiring an additional 427 shares during the last quarter. Cornercap Investment Counsel Inc. raised its holdings in Doximity by 3.2% in the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after acquiring an additional 537 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after acquiring an additional 603 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Stock Up 1.5 %

Shares of DOCS stock opened at $54.20 on Wednesday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The stock has a market capitalization of $10.12 billion, a PE ratio of 58.69, a P/E/G ratio of 4.28 and a beta of 1.40. The firm has a 50 day moving average of $46.10 and a two-hundred day moving average of $36.39.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of recent research reports. Bank of America increased their price objective on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a report on Monday, October 7th. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. JPMorgan Chase & Co. raised their price target on shares of Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a report on Thursday, November 21st. Robert W. Baird raised their price target on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, September 17th. Finally, Needham & Company LLC upgraded shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a report on Friday, August 9th. Eleven equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $52.27.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.